Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.
ISELIN, N.J., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union and the United...
Webcast replay of fireside chat now available ISELIN, N.J., Sept. 13, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory...
Topline results from NORSE EIGHT expected in Q4 CY2024 ISELIN, N.J., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved...
ISELIN, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union and the United...
Received European Union (EU) and United Kingdom (UK) Marketing Authorization for LYTENAVA™ (bevacizumab gamma) for the treatment of wet AMDNORSE EIGHT current enrollment pace supports topline...
ISELIN, N.J., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on development and commercialization of ONS-5010/LYTENAVA™...
ISELIN, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that has achieved regulatory approval in the EU and UK for the first...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.88 | -13.3942161339 | 6.57 | 6.635 | 5.57 | 454965 | 5.98442445 | CS |
4 | -1.81 | -24.1333333333 | 7.5 | 8.32 | 5.57 | 286926 | 6.66661975 | CS |
12 | -1.68 | -22.7951153324 | 7.37 | 9.25 | 5.57 | 215958 | 7.33129658 | CS |
26 | -3.05 | -34.8970251716 | 8.74 | 12.8499 | 5.57 | 285625 | 8.16517701 | CS |
52 | 1.43 | 33.5680751174 | 4.26 | 18 | 4.2 | 2535489 | 9.27505842 | CS |
156 | -40.51 | -87.683982684 | 46.2 | 48 | 4.004 | 1861089 | 15.28383568 | CS |
260 | -28.11 | -83.1656804734 | 33.8 | 85.2 | 4.004 | 1887861 | 23.51778633 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.